Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
$4.55−0.17 (-3.60%)
Close on Nov 17, 2026Market cap $2.26BP/E –Yield –
Regencell Bioscience total assets
Total assets on the balance sheet at the end of each period.
Regencell Bioscience's total assets was $14.73M at Jun 30, 2026. For fiscal 2026 it was $14.73M, up 155.9% from the year before. The highest annual figure on record is $18.02M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $14.73M | +155.9% |
| FY2025 | Jun 30, 2025 | $5.76M | -31.8% |
| FY2024 | Jun 30, 2024 | $8.44M | -33.1% |
| FY2023 | Jun 30, 2023 | $12.62M | -30.0% |
| FY2022 | Jun 30, 2022 | $18.02M | +5197.6% |
| FY2021 | Jun 30, 2021 | $340.13K | -33.8% |
| FY2020 | Jun 30, 2020 | $514.02K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $14.73M | +16.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.01M | -83.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $5.76M | +1592.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $8.44M | +1541.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $12.62M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $18.02M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $340.13K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $514.02K | – |
See a number that looks wrong?